img

Global Porcine Vaccines Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Porcine Vaccines Market Research Report 2024

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to Mr Accuracy reports new survey, global Porcine Vaccines market is projected to reach US$ 2099.7 million in 2029, increasing from US$ 1345 million in 2022, with the CAGR of 6.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Porcine Vaccines market research.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Porcine Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other

Segment by Application


Government Tender
Market Sales

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Porcine Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Porcine Vaccines Market Overview
1.1 Product Overview and Scope of Porcine Vaccines
1.2 Porcine Vaccines Segment by Type
1.2.1 Global Porcine Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Other
1.3 Porcine Vaccines Segment by Application
1.3.1 Global Porcine Vaccines Market Value by Application: (2024-2034)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Porcine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Porcine Vaccines Revenue 2018-2029
1.4.2 Global Porcine Vaccines Sales 2018-2029
1.4.3 Global Porcine Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Porcine Vaccines Market Competition by Manufacturers
2.1 Global Porcine Vaccines Sales Market Share by Manufacturers (2018-2024)
2.2 Global Porcine Vaccines Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Porcine Vaccines Average Price by Manufacturers (2018-2024)
2.4 Global Porcine Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Porcine Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Porcine Vaccines, Product Type & Application
2.7 Porcine Vaccines Market Competitive Situation and Trends
2.7.1 Porcine Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Porcine Vaccines Players Market Share by Revenue
2.7.3 Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Vaccines Retrospective Market Scenario by Region
3.1 Global Porcine Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Porcine Vaccines Global Porcine Vaccines Sales by Region: 2018-2029
3.2.1 Global Porcine Vaccines Sales by Region: 2018-2024
3.2.2 Global Porcine Vaccines Sales by Region: 2024-2029
3.3 Global Porcine Vaccines Global Porcine Vaccines Revenue by Region: 2018-2029
3.3.1 Global Porcine Vaccines Revenue by Region: 2018-2024
3.3.2 Global Porcine Vaccines Revenue by Region: 2024-2029
3.4 North America Porcine Vaccines Market Facts & Figures by Country
3.4.1 North America Porcine Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Porcine Vaccines Sales by Country (2018-2029)
3.4.3 North America Porcine Vaccines Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Porcine Vaccines Market Facts & Figures by Country
3.5.1 Europe Porcine Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Porcine Vaccines Sales by Country (2018-2029)
3.5.3 Europe Porcine Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Porcine Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Porcine Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Porcine Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Porcine Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Porcine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Porcine Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Porcine Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Porcine Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Porcine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Porcine Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Porcine Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Porcine Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Porcine Vaccines Sales by Type (2018-2029)
4.1.1 Global Porcine Vaccines Sales by Type (2018-2024)
4.1.2 Global Porcine Vaccines Sales by Type (2024-2029)
4.1.3 Global Porcine Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Porcine Vaccines Revenue by Type (2018-2029)
4.2.1 Global Porcine Vaccines Revenue by Type (2018-2024)
4.2.2 Global Porcine Vaccines Revenue by Type (2024-2029)
4.2.3 Global Porcine Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Porcine Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Porcine Vaccines Sales by Application (2018-2029)
5.1.1 Global Porcine Vaccines Sales by Application (2018-2024)
5.1.2 Global Porcine Vaccines Sales by Application (2024-2029)
5.1.3 Global Porcine Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Porcine Vaccines Revenue by Application (2018-2029)
5.2.1 Global Porcine Vaccines Revenue by Application (2018-2024)
5.2.2 Global Porcine Vaccines Revenue by Application (2024-2029)
5.2.3 Global Porcine Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Porcine Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Porcine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Boehringer Ingelheim Porcine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Corporation Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Jinyu Bio-Technology Porcine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Corporation Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 CAHIC Porcine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Corporation Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Tecon Porcine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Zoetis Porcine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ceva Porcine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Corporation Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Hile Bio Porcine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Corporation Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Chopper Biology Porcine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Corporation Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.10.4 WINSUN Porcine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Corporation Information
6.11.2 Hipra Porcine Vaccines Description and Business Overview
6.11.3 Hipra Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Hipra Porcine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Porcine Vaccines Description and Business Overview
6.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Ringpu Biology Porcine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 DHN
6.13.1 DHN Corporation Information
6.13.2 DHN Porcine Vaccines Description and Business Overview
6.13.3 DHN Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.13.4 DHN Porcine Vaccines Product Portfolio
6.13.5 DHN Recent Developments/Updates
6.14 CAVAC
6.14.1 CAVAC Corporation Information
6.14.2 CAVAC Porcine Vaccines Description and Business Overview
6.14.3 CAVAC Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.14.4 CAVAC Porcine Vaccines Product Portfolio
6.14.5 CAVAC Recent Developments/Updates
6.15 Virbac
6.15.1 Virbac Corporation Information
6.15.2 Virbac Porcine Vaccines Description and Business Overview
6.15.3 Virbac Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Virbac Porcine Vaccines Product Portfolio
6.15.5 Virbac Recent Developments/Updates
6.16 HVRI
6.16.1 HVRI Corporation Information
6.16.2 HVRI Porcine Vaccines Description and Business Overview
6.16.3 HVRI Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.16.4 HVRI Porcine Vaccines Product Portfolio
6.16.5 HVRI Recent Developments/Updates
6.17 Bioveta
6.17.1 Bioveta Corporation Information
6.17.2 Bioveta Porcine Vaccines Description and Business Overview
6.17.3 Bioveta Porcine Vaccines Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Bioveta Porcine Vaccines Product Portfolio
6.17.5 Bioveta Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Porcine Vaccines Industry Chain Analysis
7.2 Porcine Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Porcine Vaccines Production Mode & Process
7.4 Porcine Vaccines Sales and Marketing
7.4.1 Porcine Vaccines Sales Channels
7.4.2 Porcine Vaccines Distributors
7.5 Porcine Vaccines Customers
8 Porcine Vaccines Market Dynamics
8.1 Porcine Vaccines Industry Trends
8.2 Porcine Vaccines Market Drivers
8.3 Porcine Vaccines Market Challenges
8.4 Porcine Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Porcine Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Porcine Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Porcine Vaccines Sales (M Units) of Key Manufacturers (2018-2024)
Table 5. Global Porcine Vaccines Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Porcine Vaccines Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Porcine Vaccines Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Porcine Vaccines Average Price (USD/K Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Porcine Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Porcine Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Porcine Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Porcine Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Porcine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Porcine Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Porcine Vaccines Sales by Region (2018-2024) & (M Units)
Table 18. Global Porcine Vaccines Sales Market Share by Region (2018-2024)
Table 19. Global Porcine Vaccines Sales by Region (2024-2029) & (M Units)
Table 20. Global Porcine Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Porcine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Porcine Vaccines Revenue Market Share by Region (2018-2024)
Table 23. Global Porcine Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Porcine Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Porcine Vaccines Sales by Country (2018-2024) & (M Units)
Table 27. North America Porcine Vaccines Sales by Country (2024-2029) & (M Units)
Table 28. North America Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Porcine Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Porcine Vaccines Sales by Country (2018-2024) & (M Units)
Table 32. Europe Porcine Vaccines Sales by Country (2024-2029) & (M Units)
Table 33. Europe Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Porcine Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Porcine Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Porcine Vaccines Sales by Region (2018-2024) & (M Units)
Table 37. Asia Pacific Porcine Vaccines Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Porcine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Porcine Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Porcine Vaccines Sales by Country (2018-2024) & (M Units)
Table 42. Latin America Porcine Vaccines Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Porcine Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Porcine Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Porcine Vaccines Sales by Country (2018-2024) & (M Units)
Table 47. Middle East & Africa Porcine Vaccines Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Porcine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Porcine Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Porcine Vaccines Sales (M Units) by Type (2018-2024)
Table 51. Global Porcine Vaccines Sales (M Units) by Type (2024-2029)
Table 52. Global Porcine Vaccines Sales Market Share by Type (2018-2024)
Table 53. Global Porcine Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Porcine Vaccines Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Porcine Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Porcine Vaccines Revenue Market Share by Type (2018-2024)
Table 57. Global Porcine Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Porcine Vaccines Price (USD/K Unit) by Type (2018-2024)
Table 59. Global Porcine Vaccines Price (USD/K Unit) by Type (2024-2029)
Table 60. Global Porcine Vaccines Sales (M Units) by Application (2018-2024)
Table 61. Global Porcine Vaccines Sales (M Units) by Application (2024-2029)
Table 62. Global Porcine Vaccines Sales Market Share by Application (2018-2024)
Table 63. Global Porcine Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Porcine Vaccines Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Porcine Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Porcine Vaccines Revenue Market Share by Application (2018-2024)
Table 67. Global Porcine Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Porcine Vaccines Price (USD/K Unit) by Application (2018-2024)
Table 69. Global Porcine Vaccines Price (USD/K Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 73. Merck Porcine Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 78. Boehringer Ingelheim Porcine Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Jinyu Bio-Technology Corporation Information
Table 81. Jinyu Bio-Technology Description and Business Overview
Table 82. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 83. Jinyu Bio-Technology Porcine Vaccines Product
Table 84. Jinyu Bio-Technology Recent Developments/Updates
Table 85. CAHIC Corporation Information
Table 86. CAHIC Description and Business Overview
Table 87. CAHIC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 88. CAHIC Porcine Vaccines Product
Table 89. CAHIC Recent Developments/Updates
Table 90. Tecon Corporation Information
Table 91. Tecon Description and Business Overview
Table 92. Tecon Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 93. Tecon Porcine Vaccines Product
Table 94. Tecon Recent Developments/Updates
Table 95. Zoetis Corporation Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 98. Zoetis Porcine Vaccines Product
Table 99. Zoetis Recent Developments/Updates
Table 100. Ceva Corporation Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 103. Ceva Porcine Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Hile Bio Corporation Information
Table 106. Hile Bio Description and Business Overview
Table 107. Hile Bio Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 108. Hile Bio Porcine Vaccines Product
Table 109. Hile Bio Recent Developments/Updates
Table 110. Chopper Biology Corporation Information
Table 111. Chopper Biology Description and Business Overview
Table 112. Chopper Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 113. Chopper Biology Porcine Vaccines Product
Table 114. Chopper Biology Recent Developments/Updates
Table 115. WINSUN Corporation Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 118. WINSUN Porcine Vaccines Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Hipra Corporation Information
Table 121. Hipra Description and Business Overview
Table 122. Hipra Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 123. Hipra Porcine Vaccines Product
Table 124. Hipra Recent Developments/Updates
Table 125. Ringpu Biology Corporation Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 128. Ringpu Biology Porcine Vaccines Product
Table 129. Ringpu Biology Recent Developments/Updates
Table 130. DHN Corporation Information
Table 131. DHN Description and Business Overview
Table 132. DHN Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 133. DHN Porcine Vaccines Product
Table 134. DHN Recent Developments/Updates
Table 135. CAVAC Corporation Information
Table 136. CAVAC Description and Business Overview
Table 137. CAVAC Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 138. CAVAC Porcine Vaccines Product
Table 139. CAVAC Recent Developments/Updates
Table 140. Virbac Corporation Information
Table 141. Virbac Description and Business Overview
Table 142. Virbac Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 143. Virbac Porcine Vaccines Product
Table 144. Virbac Recent Developments/Updates
Table 145. HVRI Corporation Information
Table 146. HVRI Description and Business Overview
Table 147. HVRI Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 148. HVRI Porcine Vaccines Product
Table 149. HVRI Recent Developments/Updates
Table 150. Bioveta Corporation Information
Table 151. Bioveta Description and Business Overview
Table 152. Bioveta Porcine Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 153. Bioveta Porcine Vaccines Product
Table 154. Bioveta Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Porcine Vaccines Distributors List
Table 158. Porcine Vaccines Customers List
Table 159. Porcine Vaccines Market Trends
Table 160. Porcine Vaccines Market Drivers
Table 161. Porcine Vaccines Market Challenges
Table 162. Porcine Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Porcine Vaccines
Figure 2. Global Porcine Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Porcine Vaccines Market Share by Type in 2022 & 2029
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Other Product Picture
Figure 9. Global Porcine Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Porcine Vaccines Market Share by Application in 2022 & 2029
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Global Porcine Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Porcine Vaccines Market Size (2018-2029) & (US$ Million)
Figure 15. Global Porcine Vaccines Sales (2018-2029) & (M Units)
Figure 16. Global Porcine Vaccines Average Price (USD/K Unit) & (2018-2029)
Figure 17. Porcine Vaccines Report Years Considered
Figure 18. Porcine Vaccines Sales Share by Manufacturers in 2022
Figure 19. Global Porcine Vaccines Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Porcine Vaccines Players: Market Share by Revenue in 2022
Figure 21. Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Porcine Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Porcine Vaccines Sales Market Share by Country (2018-2029)
Figure 24. North America Porcine Vaccines Revenue Market Share by Country (2018-2029)
Figure 25. the United States Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Porcine Vaccines Sales Market Share by Country (2018-2029)
Figure 28. Europe Porcine Vaccines Revenue Market Share by Country (2018-2029)
Figure 29. Germany Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. UK Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Porcine Vaccines Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Porcine Vaccines Revenue Market Share by Region (2018-2029)
Figure 36. China Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Porcine Vaccines Sales Market Share by Country (2018-2029)
Figure 46. Latin America Porcine Vaccines Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Porcine Vaccines Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Porcine Vaccines Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Porcine Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Porcine Vaccines by Type (2018-2029)
Figure 56. Global Revenue Market Share of Porcine Vaccines by Type (2018-2029)
Figure 57. Global Porcine Vaccines Price (USD/K Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Porcine Vaccines by Application (2018-2029)
Figure 59. Global Revenue Market Share of Porcine Vaccines by Application (2018-2029)
Figure 60. Global Porcine Vaccines Price (USD/K Unit) by Application (2018-2029)
Figure 61. Porcine Vaccines Value Chain
Figure 62. Porcine Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed